Title: The Innovations of Harald Rau
Introduction
Harald Rau is a notable inventor based in Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release CNP agonists. Despite having no patents registered under his name, his work has the potential to impact medical treatments significantly.
Latest Patents
Harald Rau's latest inventions include two notable patents. The first is titled "Controlled-Release CNP Agonists With Reduced Side-Effects." This invention relates to a pharmaceutical composition that comprises a controlled-release CNP agonist, which aims to reduce the side effects associated with CNP agonists. The second patent is "Controlled-Release CNP Agonists With Low Initial NPR-B Activity." This invention describes a controlled-release CNP agonist that is released with a half-life of at least six hours under physiological conditions. It also emphasizes the importance of the agonist's EC50 values in comparison to the corresponding free CNP agonist.
Career Highlights
Throughout his career, Harald Rau has worked with several companies, including Complex Biosystems GmbH and Ascendis Pharma A/S. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to innovative pharmaceutical solutions.
Collaborations
Some of Harald Rau's notable coworkers include Dirk Vetter and Thomas Wegge. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.
Conclusion
Harald Rau's work in the pharmaceutical industry showcases his dedication to developing innovative solutions for medical treatments. His contributions, particularly in controlled-release CNP agonists, highlight the importance of research and collaboration in advancing healthcare.